Adtalem Global Education Inc. (NYSE:CVSA – Get Free Report) CEO Stephen Beard sold 2,529 shares of Adtalem Global Education stock in a transaction on Thursday, June 11th. The stock was sold at an average price of $130.78, for a total value of $330,742.62. Following the sale, the chief executive officer owned 424,033 shares in the company, valued at $55,455,035.74. The trade was a 0.59% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Adtalem Global Education Price Performance
Shares of NYSE CVSA traded down $3.66 during mid-day trading on Friday, reaching $128.23. 295,964 shares of the company’s stock were exchanged, compared to its average volume of 254,545. The firm has a market cap of $4.36 billion, a price-to-earnings ratio of 19.97, a price-to-earnings-growth ratio of 1.09 and a beta of 0.62. Adtalem Global Education Inc. has a 52 week low of $86.97 and a 52 week high of $156.26. The company has a quick ratio of 0.70, a current ratio of 0.70 and a debt-to-equity ratio of 0.36. The stock has a 50-day moving average price of $120.70.
Adtalem Global Education (NYSE:CVSA – Get Free Report) last released its earnings results on Thursday, May 7th. The company reported $1.98 EPS for the quarter, topping analysts’ consensus estimates of $1.73 by $0.25. The company had revenue of $487.03 million for the quarter. Adtalem Global Education had a return on equity of 20.19% and a net margin of 12.26%.The company’s revenue for the quarter was up 4.5% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.92 earnings per share. Adtalem Global Education has set its FY 2026 guidance at 7.950-8.150 EPS. As a group, sell-side analysts forecast that Adtalem Global Education Inc. will post 8.04 EPS for the current fiscal year.
Wall Street Analysts Forecast Growth
Get Our Latest Analysis on Adtalem Global Education
Adtalem Global Education Company Profile
Adtalem Global Education (NYSE: CVSA) is a provider of higher education and workforce solutions focused primarily on programs that prepare students for professional careers in healthcare, medicine, veterinary medicine and related fields. The company operates campus-based and online degree programs, continuing professional education, clinical training and exam-preparation offerings designed to support students seeking licensure and employment in regulated professions.
Adtalem’s portfolio includes institution brands that deliver undergraduate, graduate and professional training across nursing, medicine, veterinary medicine and allied health disciplines.
Featured Stories
- Five stocks we like better than Adtalem Global Education
- SpaceX Rings the Bell and Shatters Every Record
- Adobe Stock Just Got Cheaper—Is Wall Street Missing the Story?
- 3 Dividend Stocks Under $50 That Pay You to Wait Out Inflation
- The 127-Gigawatt Problem: Why AI Needs Its Own Power
Receive News & Ratings for Adtalem Global Education Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Adtalem Global Education and related companies with MarketBeat.com's FREE daily email newsletter.
